CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
The role and prospect of tofacitinib in patients with ulcerative colitis
Jun Lee
Intest Res. 2023;21(1):168-169.   Published online November 14, 2022
DOI: https://doi.org/10.5217/ir.2022.00098

Excel Download

The role and prospect of tofacitinib in patients with ulcerative colitis
Jun Lee
Intestinal Research. 2023;21(1):168-169   Crossref logo
Link1 Link2 Link3
Fr538 THE EFFECT OF TOFACITINIB ON SERUM LIPIDS AND CARDIOVASCULAR SAFETY IN PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE TOFACITINIB OCTAVE ULCERATIVE COLITIS CLINICAL PROGRAM
Séverine Vermeire, Alessandro Armuzzi, Kenneth K. Kwok, Nervin Lawendy, John Woolcott, Leonardo Salese, Chinyu Su, David Hudesman
Gastroenterology. 2021;160(6):S-353   Crossref logo
Link1 Link2
P684 The effect of tofacitinib on serum lipids and cardiovascular safety in patients with ulcerative colitis: updated results from the tofacitinib ulcerative colitis clinical programme
B E Sands, P R Taub, B G Feagan, A Armuzzi, A O Damião, N Lawendy, G Solano, K Kwok, J Woolcott, L Salese, C Su
Journal of Crohn's and Colitis. 2020;14(Supplement_1):S557-S558   Crossref logo
Link1 Link2
Tu1856 THE EFFECT OF TOFACITINIB ON SERUM LIPIDS AND CARDIOVASCULAR SAFETY IN PATIENTS WITH ULCERATIVE COLITIS - UPDATED RESULTS FROM THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAM
Bruce E. Sands, Pam R. Taub, Brian G. Feagan, Alessandro Armuzzi, Aderson O. Damiao, Nervin Lawendy, Gaston Solano, Kenneth Kwok, John Woolcott, Leonardo Salese, Chinyu Su
Gastroenterology. 2020;158(6):S-1190   Crossref logo
Link1 Link2
Sa1750 - The Effect of Tofacitinib on Serum Lipids and Cardiovascular Safety in Patients with Ulcerative Colitis - Results from the Tofacitinib Ulcerative Colitis Clinical Program
Bruce E. Sands, Pam R. Taub, Brian G. Feagan, Alessandro Armuzzi, Gary S. Friedman, Michele Moscariello, Nervin Lawendy, Ronald D. Pedersen, Gary Chan, Chudy I. Nduaka, Daniel Quirk, Leonardo Salese, Chinyu Su
Gastroenterology. 2018;154(6):S-380   Crossref logo
Link1 Link2
P471 Real-world experience of using Tofacitinib in Ulcerative Colitis in biologic naïve and biologic exposed patients
J Cheesbrough, M N Quraishi, N Sharma, I Nassar
Journal of Crohn's and Colitis. 2022;16(Supplement_1):i443-i444   Crossref logo
Link1 Link2
Clinical Efficacy of Tofacitinib in Moderate to Severe Ulcerative Colitis
Alexander Clevewood Ng
Journal of Crohn's and Colitis. 2021;15(10):1774-1774   Crossref logo
Link1 Link2 Link3
Tofacitinib for acute severe ulcerative colitis: a systematic review
Casper Steenholdt, Pernille Dige Ovesen, Jørn Brynskov, Jakob Benedict Seidelin
Journal of Crohn's and Colitis. 2023;   Crossref logo
Link1 Link2
P662 Efficacy and safety of tofacitinib in patients with moderate-to-severe ulcerative colitis: A real-world retrospective study
N Yoshimura, Soh Okano, Minako Sako, Masakazu Takazoe
Journal of Crohn's and Colitis. 2020;14(Supplement_1):S545-S545   Crossref logo
Link1 Link2
Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program
Edward V Loftus, Daniel C Baumgart, Krisztina Gecse, Jami A Kinnucan, Susan B Connelly, Leonardo Salese, Chinyu Su, Kenneth K Kwok, John C Woolcott, Alessandro Armuzzi
Inflammatory Bowel Diseases. 2022;   Crossref logo
Link1 Link2